Nuvo Pharmaceuticals™ Inc. Announces Results from European Ankle Sprain Study with Pennsaid® 2%

 – Pennsaid 2% Already Approved for Osteoarthritis of the Knee in the United States –

MISSISSAUGA, ON, March 7, 2016 /CNW/ – Nuvo Pharmaceuticals Inc. (TSX:NRI) (Nuvo or the Company) today announced top line results from its multi-centre, randomized, placebo-controlled,…